SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : The Stock for 1999(Polymedica)PLMD(Medical Supply Co.)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Arthur Radley who wrote (2420)1/20/1999 6:23:00 PM
From: Abuckatatime  Read Replies (1) of 3414
 
Another drawback.

A "real-time" problem exists when using urine samples to monitor glucose levels. Urine collects over hours in the bladder before being voided. A urine glucose measurement will give an indication of what the average blood glucose levels were during the interval between voidings. It does not indicate what the blood levels are at the moment. In type 1 individuals, especially those who are especially labile or who are attempting to maintain tight glucose control, obtaining accurate real-time measurements can be particularly important. The accuracy of urine testing can be improved via a double void procedure but still there is an inherent inaccuracy because of the delay between urine filtration in the kidneys and collection at the urethra. Placement of a catheter might enhance accuracy but I doubt many would choose this option.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News